Evaluating Retreat Claims
How to read claims made by psychedelic retreats and ceremonies, what surveys report about adverse effects and misconduct, and the legal and safety questions to ask.
Content last updated . This page has not been medically reviewed.
What this page does and does not do
Retreats and ceremonies advertise many things: healing, transformation, safety and tradition. This page helps you read those claims critically. It has no listings, no booking help and no guidance on taking any substance. A retreat is not the same as a clinical trial, and not the same as a licensed service in a place that has created one.Evidence labels: mixed, insufficient evidence and marketing claim (a statement made to attract clients, not shown by the sources read).
Three different things sold under one word
- Clinical trials follow a written protocol, with screening and trained monitors. See clinical monitoring.
- Licensed supervised services, such as the psilocybin program in Oregon, USA. The state health authority says it licenses and regulates psilocybin products and services, and that each licensed center and facilitator manages its own operations and communication with clients. [1] See supervised-service frameworks.
- Other retreats and ceremonies, which may be traditional, commercial, or somewhere in between. Their rules depend on the place and the substance, and a retreat's own description of its safety is a marketing claim unless you can check it.
Legal questions
Laws change and differ widely, and this is not legal advice. What we read as of 2026-10-22:- In the United States, FDA's guidance says many psychedelic drugs are Schedule I substances under the Controlled Substances Act. [2]
- In Oregon, a state law created licensing for psilocybin services. [1] That does not make psilocybin generally legal there or elsewhere.
We did not read the law for other countries on this page. A retreat's own statement that an activity is "legal" is not a source. See psychedelic legal status by country. Ask what law the retreat relies on, where it operates, and what happens to participants if the rules change or if the substance crosses a border.
What surveys report
These studies do not show how common problems are across all retreats. Participants chose to take part, and people with bad outcomes may be less likely to answer.- Ayahuasca, Global Ayahuasca Survey, 10,836 respondents. 69.9% reported acute physical adverse effects, primarily vomiting, and 2.3% needed medical attention afterward. Physical adverse effects were linked to taking ayahuasca in a non-supervised context, among other factors. [3] Around 12% sought professional support for the mental health effects they had. [3]
- Case series, 40 first-time ceremony participants. Seven had intense challenging reactions. The authors say an inappropriate setting, including poor guiding skills and screening, contributed to some of them. [4]
- Misconduct. In an online survey of 1,221 people who had used psychedelics, 8% said they or someone they know was a victim of inappropriate sexual contact by a sitter, guide or practitioner. [5] A bioethics paper also refers to publicized misconduct cases involving guides, facilitators and shamans at psychedelic retreats. [6] This is not a rate, and it is not a statement about any specific retreat.
Ayahuasca has its own page: ayahuasca. Medicine interactions are covered on the interactions pages, so do not assume a retreat has checked yours.
A claims checklist
- What exactly is used? Ask for the substance and the source, in plain words. A preparation, a plant, and an isolated compound are different things: clinical vs nonmedical formulations.
- Who screens participants, and how? In the Oregon licensed-center study, callers posing as people with depression reached 15 of 22 centers, none of which allowed unsupervised use or immediate dosing without psychiatric assessment, and none recommended stopping antidepressants. [7] If a retreat offers no real screening, note that. See screening and eligibility.
- What medical backup is there? Ask who is on site, what training they have, and how far the nearest hospital is.
- What do the guides do about consent and touch? See professional boundaries.
- Where do complaints go? For a licensed Oregon service, the state health authority takes complaints. [8] For other settings we could not verify a route.
- What happens afterward? See follow-up and ongoing care.
- What claims are made about outcomes? "Heals trauma," "cures depression" and similar are claims that need trial evidence. See psychedelic clinical trials and research limits.
Safety note
If you or someone else is in danger, call 911 (US). For crisis support in the US, call or text 988. See also when to seek urgent help.Frequently asked questions
Are retreats regulated?
It depends on place and substance. Oregon has a state license system for psilocybin services. [1] We did not read other places' laws for this page.
Are ceremonies safe if run by experienced guides?
We found no source that can say so in general. Surveys report frequent physical and mental adverse effects, and a case series linked some to poor guiding and screening. [3][4]
Is a retreat the same as clinical treatment?
No. Clinical trials follow protocols with monitors and screening, and FDA's guidance describes expected safety monitoring for trials. [2]
Can this page help me choose a retreat?
No. It contains no listings or recommendations.
References
- Oregon Psilocybin Program overview (Oregon Health Authority). Read 2026-10-22.
- Psychedelic Drugs: Considerations for Clinical Investigations (FDA guidance for industry). Read 2026-10-22.
- Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey (PLOS Global Public Health, 2022). Read 2026-10-22.
- Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series (Journal of Clinical Psychopharmacology, 2021). Read 2026-10-22.
- Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users (Psychedelic Medicine, 2025). Read 2026-10-22.
- Supportive Touch in Psychedelic Assisted Therapy (American Journal of Bioethics, 2025). Read 2026-10-22.
- "Am I a candidate for magic mushrooms?" A mystery shopper study of Oregon psilocybin service centers (Health Affairs Scholar, 2026). Read 2026-10-22.
- Oregon Psilocybin Services - File a Complaint (Oregon Health Authority). Read 2026-10-22.